1/31/2023  5:36:04 PM Chg. +0.120 Volume Bid1/31/2023 Ask1/31/2023 Market Capitalization Dividend Y. P/E Ratio
6.360EUR +1.92% 0
Turnover: 0.000
-Bid Size: - -Ask Size: - 99.74 mill.EUR - -

Business description

Vita 34 was founded in 1997 as the first private umbilical cord blood bank in Europe and, as a complete provider, offers collection logistics, preparation and storage of umbilical cord blood and cord tissue. The basis for its successful work is an outstanding position in the technological segment of cryo-preservation. Here, cells and tissue are preserved alive at some -190ºC for long periods of time, and can be used if needed in the context of medical treatment.
 

Management board & Supervisory board

CEO
Jakub Baran
Management board
Dirk Plaga, Tomasz Baran
Supervisory board
Florian Schuhbauer, Steffen Richtscheid, Andreas Füchsel, Frank Köhler
 

Company data

Name: VITA 34 AG
Address: Deutscher Platz 5,D-04103 Leipzig
Phone: +49-341-48792-0
Fax: +49-341-48792-20
E-mail: info@vita34.com
Internet: www.vita34.de
Industry: Biotechnology
Sector: Biotechnology
Sub sector: Biotechnology
End of financial year: 12/31
Free Float: 21.93%
IPO date: 3/27/2007

Investor relations

Name: Dr. Wolfgang Knirsch
IR phone: +49-341-48792-40
IR Fax: +49-341-48792-39
IR e-mail: ir@vita34group.de

Main Shareholders

AOC Health GmbH
 
54.98%
Freefloat
 
21.93%
Nationale-Nederlanden Otwarty Fundusz Emerytalny
 
9.99%
Hauck & Aufhäuser Privatbankiers AG
 
4.98%
PBKM
 
3.87%
Jakub Baran
 
3.21%
Dr. Peter Haueisen
 
1.04%
Others
 
0.00%